Literature DB >> 17211546

Bactericidal monoclonal antibody against Moraxella catarrhalis lipooligosaccharide cross-reacts with Haemophilus Spp.

Raina T Gergova1, Ianko D Iankov, Iana H Haralambieva, Ivan G Mitov.   

Abstract

Monoclonal antibodies (MAbs) against lipooligosaccharide (LOS) determinants after immunization of BALB/c mice with heat inactivated Moraxella catarrhalis serotype A were generated. MAb 219A9 was specific for a common epitope of A, B, and C M. catarrhalis serotypes in ELISA and immunofluorescent test (IFT). In both tests it also cross-reacted with whole bacteria and LPS antigens isolated from non-typeable H. influenzae and H. parainfluenzae strains. IgM antibody clone 219A9 possessed a strong bactericidal effect against the three serotypes in the presence of complement. Our results demonstrate that antibodies directed to a single LOS epitope common for A, B, and C serotype could be highly protective. This suggests that the common determinants are very promising in the development of LOS-based vaccine against M. catarrhalis. The cross-reactions of MAb 219A9 with Haemophilus spp. also show that immunization could result in immune response to epitopes conserved in other important respiratory pathogens.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17211546     DOI: 10.1007/s00284-005-0463-6

Source DB:  PubMed          Journal:  Curr Microbiol        ISSN: 0343-8651            Impact factor:   2.188


  33 in total

1.  Production of BRO beta-lactamases and resistance to complement in European Moraxella catarrhalis isolates.

Authors:  Franz-Josef Schmitz; Andreas Beeck; Mirella Perdikouli; Mechthild Boos; Susanne Mayer; Sybille Scheuring; Karl Köhrer; Jan Verhoef; Ad C Fluit
Journal:  J Clin Microbiol       Date:  2002-04       Impact factor: 5.948

Review 2.  Immunoprophylaxis and immunotherapy of gram-negative sepsis and shock with antibodies to core glycolipids and lipid A of bacterial lipopolysaccharides.

Authors:  I G Mitov; D G Terziiski
Journal:  Infection       Date:  1991 Nov-Dec       Impact factor: 3.553

Review 3.  Bacterial infection in chronic obstructive pulmonary disease in 2000: a state-of-the-art review.

Authors:  S Sethi; T F Murphy
Journal:  Clin Microbiol Rev       Date:  2001-04       Impact factor: 26.132

4.  Intranasal immunization with a lipooligosaccharide-based conjugate vaccine from nontypeable Haemophilus influenzae enhances bacterial clearance in mouse nasopharynx.

Authors:  Takashi Hirano; Yingchun Hou; Xinan Jiao; Xin-Xing Gu
Journal:  FEMS Immunol Med Microbiol       Date:  2003-01-21

5.  Functional characteristics of a protective monoclonal antibody against serotype A and C lipooligosaccharides from Moraxella catarrhalis.

Authors:  W G Hu; J Chen; J C McMichael; X X Gu
Journal:  Infect Immun       Date:  2001-03       Impact factor: 3.441

6.  Tetrameric repeat units associated with virulence factor phase variation in Haemophilus also occur in Neisseria spp. and Moraxella catarrhalis.

Authors:  I R Peak; M P Jennings; D W Hood; M Bisercic; E R Moxon
Journal:  FEMS Microbiol Lett       Date:  1996-03-15       Impact factor: 2.742

Review 7.  Vaccines for Moraxella catarrhalis.

Authors:  J C McMichael
Journal:  Vaccine       Date:  2000-12-08       Impact factor: 3.641

8.  Comparative immunochemistry of lipopolysaccharides from Branhamella catarrhalis strains.

Authors:  J S Fomsgaard; A Fomsgaard; N Høiby; B Bruun; C Galanos
Journal:  Infect Immun       Date:  1991-09       Impact factor: 3.441

9.  Use of serology to diagnose pneumonia caused by nonencapsulated Haemophilus influenzae and Moraxella catarrhalis.

Authors:  L A Burman; M Leinonen; B Trollfors
Journal:  J Infect Dis       Date:  1994-07       Impact factor: 5.226

10.  Antibody response in rabbits to serotype-specific determinants in lipopolysaccharides from Moraxella catarrhalis.

Authors:  M Rahman; T Holme
Journal:  J Med Microbiol       Date:  1996-05       Impact factor: 2.472

View more
  5 in total

1.  Multiplexed bead-based mesofluidic system for detection of food-borne pathogenic bacteria.

Authors:  Sheng-Quan Jin; Bin-Cheng Yin; Bang-Ce Ye
Journal:  Appl Environ Microbiol       Date:  2009-08-28       Impact factor: 4.792

Review 2.  A Moraxella catarrhalis vaccine to protect against otitis media and exacerbations of COPD: An update on current progress and challenges.

Authors:  Antonia C Perez; Timothy F Murphy
Journal:  Hum Vaccin Immunother       Date:  2017-10-03       Impact factor: 3.452

3.  Galactose residues on the lipooligosaccharide of Moraxella catarrhalis 26404 form the epitope recognized by the bactericidal antiserum from conjugate vaccination.

Authors:  Shengqing Yu; Hang Xie; Anup Datta; Natasha Naidu; Xin-Xing Gu
Journal:  Infect Immun       Date:  2008-06-16       Impact factor: 3.441

4.  Shielding of a lipooligosaccharide IgM epitope allows evasion of neutrophil-mediated killing of an invasive strain of nontypeable Haemophilus influenzae.

Authors:  Jeroen D Langereis; Jeffrey N Weiser
Journal:  MBio       Date:  2014-07-22       Impact factor: 7.867

Review 5.  Potential targets for next generation antimicrobial glycoconjugate vaccines.

Authors:  Francesca Micoli; Paolo Costantino; Roberto Adamo
Journal:  FEMS Microbiol Rev       Date:  2018-05-01       Impact factor: 16.408

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.